NGS Sample Preparation Market Scope
NGS Sample Preparation is defined as technology in which millions, as well as billions of DNA strands, can be sequenced through massive parallelization. It is also identified as a high throughput sequencing. Growth in the number of genome mapping programs throughout the world and increase in R&D investment, among others will, in turn, propel the growth of hemp milk market.
According to AMA, the Global NGS Sample Preparation market is expected to see growth rate of 21.2%
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global NGS sample preparation market can witness an upsurge in the forecast period. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global NGS Sample Preparation market throughout the predicted period.
Illumina Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (United States), Beckman Coulter (United States), Becton, Dickinson, and Company (United States), Pacific Biosciences of California (United States), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (United States) and Nugen Technologies, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Oxford Gene Technology IP Limited (United Kingdom), Oxford Nanopore Technologies, Ltd. (United Kingdom), Perkinelmer, Inc. (United States) and Swift Biosciences Inc. (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global NGS Sample Preparation market , by Application (Whole Genome Sequence (WGS), Exome Sequencing, RNA Sequencing and Methylation Sequencing) and Region with country level break-up.
On the basis of geography, the market of NGS Sample Preparation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In November 2018, the Illumina Inc. (United States) has entered into an agreement to acquire Pacific Biosciences of California, Inc. (United States) Company for more than USD 1.2 Billion. Henceforth, this would help in enhancing the customer base of the company. and In August 2018, the Tecan Group Ltd. (Switzerland ) Company has acquired NuGEN Technologies, Inc. (United States) Company, which is a United States based sequencing sample prep company. Therefore, it will affect therewith of, the market in the future.
In January 2019, the QIAGEN N.V. (Germany) Company launched its QIAcube Connect, which automates the lysis, bind, wash, and elute steps of the Qiagen spin columns. Hence, this will, in turn, propel the growth of NGS Sample Preparation market. and In April 2018, the Thermo Fisher Scientific (United States) Company has launched its Oncomine Childhood Cancer Research Assay, which is a comprehensive, next-generation sequencing (NGS) panel. Consequently, this launch will help in strengthening the position of the company
Market Trend
- Technology Advancement in NGS Sample Preparation
Market Drivers
- Advancements in NGS Platforms
- Declining Cost of Sequencing
- Improving Reimbursement Scenario for NGS-Based Diagnostic Tests
Opportunities
- Initiatives as well as Funding from Government & Private Bodies for Large-Scale Sequencing Projects
- Increasing Applications of Next Generation Sequencing (NGS)
Restraints
- End User Budget Constraints in Developing Countries
- High-Cost Factor associated with reagent and Sample Preparation for Testing
Challenges
- Ethical Issues Regarding the Sample Taken From For Testing
Key Target Audience
Manufacturers of Next Generation Sequencing, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others